21 results
Thumbnail

D2.134 - Transitioning adolescents and young adults with asthma: insights from a severe asthma series

Thumbnail

D2.133 - Clinical and Direct Medical Burden of Hospitalized Children with Asthma Exacerbations

Thumbnail

D2.135 - What are our children breathing? Tracking exposure to air pollution during a school day

Thumbnail

D2.136 - Nasal transcriptomics as a biomarker for ICS/LABA treatment in paediatric asthma in the PUFFIN study

Thumbnail

D2.137 - Long term, Persistent Eosinophilia in patients with Asthma and CRSwNP undergoing Dupilumab therapy: preliminar results of a 24-month follow up prospective study

Thumbnail

D2.138 - The Effect of Human Milk Oligosaccharides 2’FL and 3FL on Macrophage polarization

Thumbnail

D2.139 - Oxidative stress and tissue hypoxia are triggered through the increased respiratory effort during sleep and reflect the inflammation as a stress link in the gut-brain axis in children suffering asthma, allergic/non-allergic rhinitis, and/or eczema

Thumbnail

D2.140 - Allergic Sensitization Patterns in Western Romania: Impact of Airborne Allergens and Climate Factors

Thumbnail

D2.142 - Smoking cessation advice to parents in children with bronchial asthma- still it is a long way to go

Thumbnail

D2.144 - Occupational Asthma due to garlic powder: a case report

Thumbnail

D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis

Thumbnail

D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge

Thumbnail

D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy

Thumbnail

D3.395 - Evaluation for suspected penicillin allergy - the patient perspective